d2,s6,s5-implementing gdufa science in product development & andas: realizations & recommendations
Published 2 years ago • 81 plays • Length 15:05
Download video MP4
Download video MP3
Similar videos
-
17:31
d2,s5,s7-how can scientific advancements help align global development of complex generic products?
-
14:36
d2,s6,s1-from the bench to approval: the role of gdufa research in promoting complex generics
-
14:41
d2,s7,s1-pre-anda evaluation of drug delivery device constituent
-
1:31:52
complex generics: topical products, part 2
-
35:13
episode 11: multiple function device products - policy and considerations
-
11:13
d2,s5,s5-single global development: a key to unlocking access
-
16:38
do you know the difference between a medical device component and an accessory medical device?
-
3:53
multi-function device (mfd) how-to
-
9:05
drug device combination products | episode 06 - how to select notified body in eu?
-
19:58
lab science to support generic complex drug product assessment
-
19:04
d2,s5,s6-challenges and opportunities for global development
-
13:33
d2,s7,s5-leveraging device functional assessment to classify & evaluate user interface differences
-
35:01
combination products: user-interface & role of comparative analyses (29of39) complex generics 2018
-
23:49
us drug delivery combination product regulatory
-
19:10
product-specific guidances for complex generic drugs
-
0:20
drug device combination products certificate for medical devices
-
24:53
episode 24: requesting fda feedback on combination products
-
7:53
d2,s5,s1-current challenges to complex generic drug development under divergent global regulations
-
1:53
device/drug combinations
-
15:05
d2,s5,s3-expansion of biowaivers and global development of generic products
-
11:10
what constitutes complex drug-device combination (18of35) complex generics – sep. 25-26, 2019
-
14:56
d2,s6,s6-implementing gdufa science: industry perspectives
Clip.africa.com - Privacy-policy